InvestorsObserver
×
News Home

Should You Add Dyne Therapeutics Inc (DYN) Stock to Your Portfolio Wednesday?

Wednesday, March 20, 2024 11:37 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Add Dyne Therapeutics Inc (DYN) Stock to Your Portfolio Wednesday?

Dyne Therapeutics Inc (DYN) is near the top in its sector according to InvestorsObserver. DYN gets an overall rating of 85. That means it scores higher than 85% of stocks. Dyne Therapeutics Inc gets a 92 rank in the Healthcare sector. Healthcare is number 1 out of 11 sectors.

Overall Score - 85
DYN has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on DYN!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Dyne Therapeutics Inc Stock Today?

Dyne Therapeutics Inc (DYN) stock has fallen -0.05% while the S&P 500 is higher by 0.05% as of 11:27 AM on Wednesday, Mar 20. DYN has fallen -$0.02 from the previous closing price of $27.52 on volume of 132,058 shares. Over the past year the S&P 500 has gained 29.43% while DYN is higher by 130.79%. DYN lost -$3.95 per share the over the last 12 months. Click Here to get the full Stock Report for Dyne Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App